Morning Market Losers
April 07, 2015 at 09:46 AM EDT
Ocular Therapeutix, Inc. (NASDAQ: OCUL) shares fell 19.84% to $30.70 after the company issued topline clinical data for second Phase ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.